U.S. Specialty Stores Stock News

If you are wondering whether Corning’s share price still reflects fair value after a strong run, you are not alone. The stock closed at US$85.23, with returns of 84.3% over 1 year, 156.8% over 3 years and 158.7% over 5 years, although the last 7 days and 30 days saw declines of 6.0% and 9.5% respectively. Recent headlines around Corning have focused on its position in glass and material technologies and how that ties into demand from electronics and communications end markets. This context...

In its latest quarterly update, Packaging Corporation of America reported revenue roughly in line with expectations but earnings per share below analyst forecasts, as management pointed to solid legacy packaging performance alongside ongoing pressure in export containerboard demand. This combination of steady core operations and weaker profitability has sharpened attention on how efficiently the company can convert resilient box demand into earnings. Next, we’ll examine how this...

In early January 2026, Archrock announced that its subsidiary Archrock Services, L.P. priced an upsized private offering of US$800,000,000 in 6.000% senior notes due 2034, with proceeds earmarked to repay a portion of borrowings under its revolving credit facility. This refinancing step reshapes Archrock’s capital structure by extending debt maturities and shifting borrowings from a revolving credit line into longer-term fixed-rate notes. We’ll now examine how issuing US$800,000,000 of...

With no single headline event driving attention, Crane NXT (CXT) is on some investors’ radar after recent price swings, including a 1.2% daily gain and mixed returns over the past 3 months. See our latest analysis for Crane NXT. The recent 1-day share price return of 1.15% and 7-day share price return of 4.71% sit against a 30-day share price return decline of 12.52% and a 90-day share price return decline of 23.78%. Meanwhile, the year to date share price return of 4.71% contrasts with a...

Aveanna Healthcare Holdings (AVAH) has drawn fresh attention after recent research highlighted its value-focused rating and earnings outlook, along with improving revenue trends and guidance that have contributed to a strong share price recovery. See our latest analysis for Aveanna Healthcare Holdings. At a share price of $8.59, Aveanna’s recent moves have come after a strong run, with a year-to-date share price return of 6.31% and a 1-year total shareholder return of 90.47%. The 3-year total...

Moog Inc. recently reached a 52-week high following a run of earnings results that exceeded analyst expectations in each of the past four quarters, while analysts have revised their estimates upward and assigned the company a favorable Zacks Rank of #2 (Buy). Alongside this performance, Moog’s decision to feature its CEO and CFO at the CJS Securities virtual conference highlights management’s intent to spotlight the company’s earnings track record and outlook to a wider institutional...

Global-E Online recently reported that it had become profitable ahead of schedule and was accelerating its expansion in cross-border e-commerce through deeper integration with Shopify and enhanced localization, payments, logistics, and compliance tools. This shift to profitability, combined with its ability to simplify complex taxes, duties, and regulations for merchants, is reinforcing Global-E's role as a key enabler of international direct-to-consumer commerce despite intense competition...

PennyMac Financial Services (PFSI) surprised the market with quarterly earnings and revenue that came in ahead of expectations, followed by a wave of more positive analyst outlooks and increased investor interest in the stock. See our latest analysis for PennyMac Financial Services. The strong quarterly result comes after a period of solid momentum, with a 1-day share price return of 6.41% and a 90-day share price return of 24.83%, while the 1-year total shareholder return of 53.66% and...

If you are wondering whether Jack Henry & Associates is priced fairly or not, this is where we start connecting the share price to what you are actually paying for. The stock last closed at US$189.16, with returns of 6.1% over the past week, 1.1% over the last month, 6.1% year to date, 11.5% over 1 year, 8.3% over 3 years and 30.2% over 5 years. This gives some context for how the market has been reassessing the company. Recent coverage has focused on Jack Henry & Associates as a key player...

XPO recently renewed its long-standing role as the official transportation partner for the Susan G. Komen 3-Day fundraising walks through March 2029, continuing to provide complimentary transport, storage and logistics support for event materials across all route cities. This extended partnership underscores how XPO integrates community engagement into its core logistics capabilities, highlighting the company’s operational reach and brand positioning beyond purely commercial freight...

First American Financial (FAF) has drawn investor attention after its recent share moves, with the stock up 2.4% over the past day but down 3.1% over the past month. See our latest analysis for First American Financial. At a share price of $61.49, First American Financial’s recent 1 day share price return of 2.42% sits against a softer 30 day share price return of 3.10%. Its 1 year total shareholder return of 10.36% and 5 year total shareholder return of 37.93% point to steadier progress over...

Soho House & Co (SHCO) has recently drawn investor attention after a period of mixed share performance, with the stock showing a small positive 1 year total return alongside negative moves over the past week, month and past 3 months. See our latest analysis for Soho House & Co. The recent 1 day share price return of 2.59% decline, alongside weaker 7 day and 30 day share price returns, suggests fading short term momentum, even as the 3 year total shareholder return of 48.78% points to a...

If you are wondering whether BeOne Medicines is priced for opportunity or already reflecting high expectations, you will want to look closely at what its current valuation is really saying. The stock recently closed at US$337.89, with returns of 8.6% over the last 7 days and 91.2% over the past year, which may signal that the market is reassessing its growth potential or risk profile. Recent coverage around BeOne Medicines has focused on its position within the pharmaceuticals and biotech...

If you are wondering whether Procter & Gamble’s current share price offers fair value or not, you are not alone. This article is built to help you size that up clearly. The stock last closed at US$141.87, with returns of 0.1% over 7 days, 1.5% over 30 days, 0.1% year to date, an 8.2% decline over 1 year and 19.3% over 5 years. These figures may have some investors reassessing both its growth potential and risk profile. Recent coverage has focused on Procter & Gamble as a staple name in...

If you are wondering whether Wyndham Hotels & Resorts is attractively priced right now, it helps to first step back and see how the stock has been behaving. The share price closed at US$81.11, with recent returns of 7.8% over 7 days, 7.2% over 30 days, 7.8% year to date and a 17.7% decline over 1 year, alongside gains of 16.7% over 3 years and 45.6% over 5 years. These mixed returns sit against a backdrop of ongoing industry news around travel demand, brand consolidation and competition...

If you are wondering whether Principal Financial Group's share price still offers value at around US$90, you are not alone, as many investors are asking the same question after its recent run. The stock recently closed at US$90.29, with returns of 1.0% over the past week, 0.1% over the last month, 1.0% year to date and 22.9% over the past year, as well as 12.7% over three years and 102.9% over five years. Recent attention on Principal Financial Group has been shaped by ongoing coverage of...

Rolex lease in Williamsburg puts fresh attention on Empire State Realty Trust Empire State Realty Trust (ESRT) recently signed a lease with Tourneau, LLC for a Rolex retail store at its North Sixth Street Collection in Williamsburg, Brooklyn. The agreement is drawing fresh attention to the REIT's retail footprint and leasing activity. See our latest analysis for Empire State Realty Trust. The Rolex lease and upcoming fourth quarter 2025 results arrive after a weak stretch for the shares, with...

If you are wondering whether Versant Media Group at around US$34.41 is a bargain or a value trap, you are not alone. This article will walk through what the current price might be implying. The stock has had a sharp 26.2% decline over the last 7 days and year to date, which can change how investors think about both its growth potential and its risk. Recent coverage of Versant Media Group has focused on how quickly sentiment can shift around media stocks, with some investors reacting to...

AvalonBay Communities recently confirmed it will release its fourth-quarter 2025 earnings on February 4, 2026, followed by a conference call on February 5 where management will review operating trends, development activity, and outlook. This update comes after Q3 2025 core FFO missed expectations and management flagged softer rental demand in some key markets amid elevated supply. We’ll now examine how the upcoming earnings release and softer rental demand backdrop may influence AvalonBay...

Why Celldex Therapeutics Stock Is Back on Watch With no single headline event driving attention today, Celldex Therapeutics (CLDX) is drawing interest as investors reassess a clinical stage pipeline, recent share performance and the company’s current valuation setup. See our latest analysis for Celldex Therapeutics. The share price at US$27.38 comes after a mixed stretch, with a modest 7 day share price return of 1.37%, a slightly negative 30 day share price return, and a 1 year total...

Central Securities Corp reported in late 2025 that CEO and President John C. Hill bought 500 shares on December 29, increasing his direct holdings to 77,373 shares alongside 901 shares held indirectly through his children. This insider purchase came shortly after the company disclosed that net assets had risen 9.3% to US$1.78 billion as of September 30, 2025, underscoring management’s alignment with shareholder interests. We’ll now examine how the CEO’s insider purchase, alongside rising net...

In early January 2026, Barclays began covering Ryman Hospitality Properties with an Overweight rating, while Fitch Ratings upgraded the company’s credit profile and the REIT declared a cash dividend payable in January 2026, reflecting recent past developments in its financing and capital returns. Together, the new analyst coverage and higher credit rating highlight outside confidence in Ryman’s large group-focused hotel portfolio and its ability to support its balance sheet and dividend...

Worthington Steel recently filed its latest Form 10-Q, showing growth supported by stronger automotive demand and the completed acquisition of Sitem Group, which expands its European footprint and production capabilities. An interesting takeaway is how the Sitem acquisition deepens Worthington Steel’s role in supplying automotive customers in Europe, potentially reshaping its geographic and product mix. We’ll now examine how the Sitem-driven European expansion highlighted in the 10-Q could...

Incyte (INCY) is back in focus after reporting positive Phase 3 frontMIND trial results for tafasitamab plus lenalidomide and R-CHOP in first-line diffuse large B-cell lymphoma, with plans for an expanded filing in 2026. See our latest analysis for Incyte. The frontMIND update comes after a strong run in the shares, with a 30 day share price return of 12.29% and a 90 day share price return of 27.53%, while the 1 year total shareholder return of 51.50% points to momentum building around...